Novo Nordisk A/S (NVO)
Total Valuation
Novo Nordisk has a market cap or net worth of $574.20 billion. The enterprise value is $573.73 billion.
Market Cap | 574.20B |
Enterprise Value | 573.73B |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
Earnings Date | May 2, 2024 |
Ex-Dividend Date | Mar 22, 2024 |
Share Statistics
Novo Nordisk has 4.46 billion shares outstanding.
Shares Outstanding | 4.46B |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 9.29% |
Float | 3.19B |
Valuation Ratios
The trailing PE ratio is 47.66 and the forward PE ratio is 38.17. Novo Nordisk's PEG ratio is 2.35.
PE Ratio | 47.66 |
Forward PE | 38.17 |
PS Ratio | 16.69 |
Forward PS | 2.00 |
PB Ratio | 37.30 |
P/FCF Ratio | 47.83 |
PEG Ratio | 2.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.69, with an EV/FCF ratio of 47.79.
EV / Earnings | 46.28 |
EV / Sales | 16.67 |
EV / EBITDA | 34.69 |
EV / EBIT | 37.80 |
EV / FCF | 47.79 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.25.
Current Ratio | 0.82 |
Quick Ratio | 0.56 |
Debt / Equity | 0.25 |
Debt / EBITDA | 0.24 |
Debt / FCF | 0.32 |
Interest Coverage | 277.92 |
Financial Efficiency
Return on equity (ROE) is 90.50% and return on invested capital (ROIC) is 61.40%.
Return on Equity (ROE) | 90.50% |
Return on Assets (ROA) | 29.20% |
Return on Capital (ROIC) | 61.40% |
Revenue Per Employee | $534,975 |
Profits Per Employee | $192,750 |
Employee Count | 64,319 |
Asset Turnover | 0.81 |
Inventory Turnover | 1.27 |
Taxes
In the past 12 months, Novo Nordisk has paid $3.03 billion in taxes.
Income Tax | 3.03B |
Effective Tax Rate | 19.65% |
Stock Price Statistics
The stock price has increased by +65.34% in the last 52 weeks. The beta is 0.18, so Novo Nordisk's price volatility has been lower than the market average.
Beta (1Y) | 0.18 |
52-Week Price Change | +65.34% |
50-Day Moving Average | 121.86 |
200-Day Moving Average | 100.38 |
Relative Strength Index (RSI) | 52.42 |
Average Volume (30 Days) | 5,207,737 |
Short Selling Information
Short Interest | 4.11M |
Short Previous Month | 4.67M |
Short % of Shares Out | 0.14% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.88 |
Income Statement
In the last 12 months, Novo Nordisk had revenue of $34.41 billion and earned $12.40 billion in profits. Earnings per share was $2.69.
Revenue | 34.41B |
Gross Profit | 28.39B |
Operating Income | 14.82B |
Pretax Income | 15.12B |
Net Income | 12.40B |
EBITDA | 16.54B |
EBIT | 15.18B |
Earnings Per Share (EPS) | $2.69 |
Balance Sheet
The company has $4.37 billion in cash and $3.90 billion in debt, giving a net cash position of $465.79 million or $0.10 per share.
Cash & Cash Equivalents | 4.37B |
Total Debt | 3.90B |
Net Cash | 465.79M |
Net Cash Per Share | $0.10 |
Equity / Book Value | 15.40B |
Book Value Per Share | 3.45 |
Working Capital | -4.34B |
Cash Flow
In the last 12 months, operating cash flow was $15.73 billion and capital expenditures -$3.73 billion, giving a free cash flow of $12.01 billion.
Operating Cash Flow | 15.73B |
Capital Expenditures | -3.73B |
Free Cash Flow | 12.01B |
FCF Per Share | $2.63 |
Margins
Gross margin is 82.50%, with operating and profit margins of 43.07% and 36.03%.
Gross Margin | 82.50% |
Operating Margin | 43.07% |
Pretax Margin | 43.95% |
Profit Margin | 36.03% |
EBITDA Margin | 48.06% |
EBIT Margin | 44.11% |
FCF Margin | 34.89% |
Dividends & Yields
This stock pays an annual dividend of $0.70, which amounts to a dividend yield of 0.55%.
Dividend Per Share | $0.70 |
Dividend Yield | 0.55% |
Dividend Growth (YoY) | 796.94% |
Years of Dividend Growth | 4 |
Payout Ratio | 26.02% |
Buyback Yield | -0.81% |
Shareholder Yield | -0.27% |
Earnings Yield | 2.16% |
FCF Yield | 2.09% |
Analyst Forecast
The average price target for Novo Nordisk is $104.10, which is -18.93% lower than the current price. The consensus rating is "Strong Buy".
Price Target | $104.10 |
Price Target Difference | -18.93% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 13.54% |
EPS Growth Forecast (5Y) | 14.23% |
Stock Splits
The last stock split was on September 20, 2023. It was a forward split with a ratio of 2:1.
Last Split Date | Sep 20, 2023 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Novo Nordisk has an Altman Z-Score of 13.68 and a Piotroski F-Score of 7.
Altman Z-Score | 13.68 |
Piotroski F-Score | 7 |